Dec 21, 2020 Virios Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriter’s Over-Allotment Option
Dec 18, 2020 ENDRA Life Sciences Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option
Dec 11, 2020 cbdMD, Inc. Announces Closing of $17,250,000 Underwritten Public Offering of Its 8.0% Series A Cumulative Convertible Preferred Stock
